Crass RL - Search Results

1

Vancomycin volume of distribution estimation in adults with class III obesity.

Dunn RD, Crass RL, Hong J, Pai MP, Krop LC. Dunn RD, et al. Among authors: crass rl. Am J Health Syst Pharm. 2019 Dec 2;76(24):2013-2018. doi: 10.1093/ajhp/zxz241. Am J Health Syst Pharm. 2019. PMID: 31630155

2

Measurement of Skeletal Muscle Area Improves Estimation of Aminoglycoside Clearance across Body Size.

Crass RL, Ross BE, Derstine BA, Lichty M, Sullivan JA, Su GL, Wang SC, Pai MP. Crass RL, et al. Antimicrob Agents Chemother. 2018 May 25;62(6):e00441-18. doi: 10.1128/AAC.00441-18. Print 2018 Jun. Antimicrob Agents Chemother. 2018. PMID: 29632017 Free PMC article.

3

Estimating Renal Function in Drug Development: Time to Take the Fork in the Road.

Crass RL, Pai MP. Crass RL, et al. J Clin Pharmacol. 2019 Feb;59(2):159-167. doi: 10.1002/jcph.1314. Epub 2018 Sep 5. J Clin Pharmacol. 2019. PMID: 30184267 Free article. Review.

4

Dosing vancomycin in the super obese: less is more.

Crass RL, Dunn R, Hong J, Krop LC, Pai MP. Crass RL, et al. J Antimicrob Chemother. 2018 Nov 1;73(11):3081-3086. doi: 10.1093/jac/dky310. J Antimicrob Chemother. 2018. PMID: 30203073

5

Renal Dosing of Antibiotics: Are We Jumping the Gun?

Crass RL, Rodvold KA, Mueller BA, Pai MP. Crass RL, et al. Clin Infect Dis. 2019 Apr 24;68(9):1596-1602. doi: 10.1093/cid/ciy790. Clin Infect Dis. 2019. PMID: 30219824 Review.

6

Individualizing piperacillin/tazobactam dosing in adult patients with cystic fibrosis: can tobramycin measurements help?

Crass RL, Pai MP, Lodise TP Jr. Crass RL, et al. J Antimicrob Chemother. 2019 Jan 1;74(1):126-129. doi: 10.1093/jac/dky388. J Antimicrob Chemother. 2019. PMID: 30252050

7

Pharmacokinetics and Pharmacodynamics of β-Lactamase Inhibitors.

Crass RL, Pai MP. Crass RL, et al. Pharmacotherapy. 2019 Feb;39(2):182-195. doi: 10.1002/phar.2210. Epub 2019 Jan 20. Pharmacotherapy. 2019. PMID: 30589457 Review.

8

Optimizing Estimated Glomerular Filtration Rate to Support Adult to Pediatric Pharmacokinetic Bridging Studies in Patients with Cystic Fibrosis.

Crass RL, Pai MP. Crass RL, et al. Clin Pharmacokinet. 2019 Oct;58(10):1323-1332. doi: 10.1007/s40262-019-00761-5. Clin Pharmacokinet. 2019. PMID: 30972695 Free PMC article.

9

Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety.

Crass RL, Cojutti PG, Pai MP, Pea F. Crass RL, et al. Antimicrob Agents Chemother. 2019 Jul 25;63(8):e00605-19. doi: 10.1128/AAC.00605-19. Print 2019 Aug. Antimicrob Agents Chemother. 2019. PMID: 31109977 Free PMC article.

10

Development of a sensitive LC-MS/MS method for quantification of linezolid and its primary metabolites in human serum.

Souza E, Felton J, Crass RL, Hanaya K, Pai MP. Souza E, et al. Among authors: crass rl. J Pharm Biomed Anal. 2020 Jan 30;178:112968. doi: 10.1016/j.jpba.2019.112968. Epub 2019 Nov 5. J Pharm Biomed Anal. 2020. PMID: 31727360 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page